MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-13-2025
Milestone Scientific Gross Profit 2011-2025 | MLSS
Gross profit is a key indicator of how efficiently a company produces or sells its products. This metric helps assess a business’s ability to generate revenue at the initial stage, before accounting for all other expenses. Regular analysis of gross profit allows companies to respond in a timely manner to changes in cost of goods, pricing strategy, and market conditions.
Calculation formula:Importance for business:
Gross Profit = Revenue – Cost of Goods Sold (COGS)
Revenue — all cash inflows from the sale of goods or services.
Cost of Goods Sold — direct costs related to the production or acquisition of goods:
- Raw materials and supplies
- Wages of production personnel
- Depreciation of equipment
- Transportation and warehousing costs (if directly related to production)
- Assessing core business profitability
If gross profit is declining, it may indicate rising production costs or falling sales. - Financial planning
Gross profit is the basis for calculating other key metrics, such as operating and net profit. - Benchmarking against competitors
Gross profit analysis helps compare the efficiency of different companies within the same industry. - Insights into pricing effectiveness
If gross profit is low, the company may be pricing too low or failing to control costs effectively.
- Increase in raw material and supply costs
- Rising production expenses
- Price reductions due to competition
- Decrease in sales volume
- Currency exchange rate fluctuations (for imports/exports)
Gross profit is an important metric, but it does not provide a complete picture of a company’s financial health, as it does not account for administrative and selling expenses, taxes, debt burden, or depreciation.
Annual Gross Profit Milestone Scientific
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.43 M | 6.79 M | 4.9 M | 6.31 M | 3.62 M | 5.72 M | 4.43 M | 6.97 M | 6.31 M | 6.44 M | 6.7 M | 6.81 M | 5.59 M | 5.36 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 6.97 M | 3.62 M | 5.89 M |
Quarterly Gross Profit Milestone Scientific
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.64 M | 1.62 M | 1.65 M | - | 1.84 M | 1.41 M | 1.68 M | - | 1.5 M | 1.89 M | 1.89 M | - | 1.45 M | 681 K | 1.68 M | - | 1.36 M | 1.37 M | 1.8 M | - | 836 K | 112 K | 1.28 M | - | 1.38 M | 1.51 M | 1.3 M | - | -120 K | 1.41 M | 1.24 M | - | 1.81 M | 1.65 M | 2.29 M | - | 1.67 M | 1.58 M | 2.2 M | - | 1.67 M | 1.2 M | 1.84 M | - | 1.71 M | 1.59 M | 1.74 M | - | 1.77 M | 1.53 M | 1.68 M | - | 1.5 M | 1.47 M | 1.26 M | - | 1.15 M | 1.6 M | 1.55 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 2.29 M | -120 K | 1.49 M |
Gross Profit of other stocks in the Medical instruments industry
| Issuer | Gross Profit | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Baxter International
BAX
|
959 M | $ 18.99 | 0.48 % | $ 9.68 B |  USA |
 |
Becton, Dickinson and Company
BDX
|
8.29 B | $ 200.87 | 0.22 % | $ 57.8 B | USA |
 |
BioLife Solutions
BLFS
|
18.6 M | $ 24.43 | -1.81 % | $ 1.13 B | USA |
 |
Luminex Corporation
LMNX
|
248 M | - | - | $ 1.75 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
479 K | - | -9.52 % | $ 20.6 M | USA |
 |
Ekso Bionics Holdings
EKSO
|
9.51 M | $ 4.79 | 2.35 % | $ 96.6 M | USA |
 |
DENTSPLY SIRONA
XRAY
|
1.96 B | $ 11.59 | -0.13 % | $ 2.36 B | USA |
 |
Antares Pharma, Inc.
ATRS
|
86.5 M | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
436 M | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
1.68 M | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
1.48 B | - | -0.05 % | $ 10.3 B | USA |
 |
Varian Medical Systems, Inc.
VAR
|
1.38 B | - | -0.02 % | $ 16.3 B | USA |
 |
Alcon
ALC
|
5.51 B | $ 78.74 | -0.03 % | $ 40.4 B |  Schweiz |
 |
iRhythm Technologies
IRTC
|
408 M | $ 170.09 | 0.58 % | $ 5.31 B | USA |
 |
AtriCure
ATRC
|
348 M | $ 42.08 | 1.62 % | $ 1.98 B | USA |
 |
Atrion Corporation
ATRI
|
62.4 K | - | - | $ 810 M | USA |
 |
electroCore
ECOR
|
13.2 M | $ 4.81 | -0.21 % | $ 26.5 K | USA |
 |
Harvard Bioscience
HBIO
|
66.1 M | $ 0.76 | 1.78 % | $ 32.2 M | USA |
 |
AngioDynamics
ANGO
|
158 M | $ 13.12 | -2.42 % | $ 536 M | USA |
 |
The Cooper Companies
COO
|
2.68 B | $ 81.82 | -0.36 % | $ 16.3 B | USA |
 |
ICU Medical
ICUI
|
825 M | $ 147.72 | 0.34 % | $ 3.6 B | USA |
 |
Glaukos Corporation
GKOS
|
239 M | $ 109.57 | 0.31 % | $ 5.31 B | USA |
 |
Haemonetics Corporation
HAE
|
749 M | $ 83.2 | -1.49 % | $ 4.19 B | USA |
 |
InfuSystem Holdings
INFU
|
62.6 M | $ 9.24 | 0.33 % | $ 191 M | USA |
 |
Isoray
ISR
|
817 K | - | 0.03 % | $ 108 M | USA |
 |
Repro Med Systems
KRMD
|
16.7 M | $ 5.75 | -1.88 % | $ 262 M | USA |
 |
LeMaitre Vascular
LMAT
|
151 M | $ 83.51 | 0.18 % | $ 1.87 B | USA |
 |
Intuitive Surgical
ISRG
|
5.63 B | $ 541.3 | -1.11 % | $ 192 B | USA |
 |
Masimo Corporation
MASI
|
1 B | $ 138.1 | -2.25 % | $ 7.36 B | USA |
 |
Merit Medical Systems
MMSI
|
643 M | $ 86.52 | -0.01 % | $ 5.04 B | USA |
 |
Microbot Medical
MBOT
|
117 K | $ 2.43 | 2.21 % | $ 24.8 M |  Israel |
 |
Nephros
NEPH
|
8.4 M | $ 5.08 | 2.24 % | $ 52.8 M | USA |
 |
NeuroMetrix
NURO
|
1.68 M | - | 5.05 % | $ 9.02 M | USA |
 |
ResMed
RMD
|
2.02 B | $ 250.7 | -0.67 % | $ 36.6 B | USA |
 |
Envista Holdings Corporation
NVST
|
1.37 B | $ 21.79 | -1.58 % | $ 3.75 B | USA |
 |
OraSure Technologies
OSUR
|
79.4 M | $ 2.52 | -2.14 % | $ 188 M | USA |
 |
Pro-Dex
PDEX
|
19.5 M | $ 43.83 | 0.6 % | $ 144 M | USA |
 |
Predictive Oncology
POAI
|
798 K | $ 5.95 | 0.51 % | $ 32.4 M | USA |
 |
Repligen Corporation
RGEN
|
151 M | $ 156.65 | -3.1 % | $ 8.73 M | USA |
 |
Retractable Technologies
RVP
|
-1.03 M | $ 0.83 | -0.31 % | $ 24.8 M | USA |
 |
STAAR Surgical Company
STAA
|
240 M | $ 24.16 | -2.11 % | $ 1.19 B | USA |
 |
STERIS plc
STE
|
2.4 B | $ 251.01 | -0.59 % | $ 24.7 B | USA |
 |
Stereotaxis
STXS
|
14.9 M | $ 2.38 | -1.45 % | $ 192 M | USA |
 |
Teleflex Incorporated
TFX
|
1.7 B | $ 125.81 | -1.13 % | $ 5.89 B | USA |
 |
Utah Medical Products
UTMD
|
7.1 M | $ 57.99 | 0.5 % | $ 210 M | USA |
 |
West Pharmaceutical Services
WST
|
998 M | $ 266.92 | -2.06 % | $ 19.5 B | USA |